Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 12.55% is in line with its 5-year average of 11.76%, around the middle of its 5-year range (8.81%–16.16%).
0.75% below its 12-month average of 12.64%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 13.55%.
GROSS MARGIN
12.55%
GROSS MARGIN AVG TTM
12.64%
GROSS MARGIN AVG 3Y
11.99%
GROSS MARGIN AVG 5Y
11.76%
GROSS MARGIN AVG 10Y
N/A
GROSS MARGIN AVG 15Y
N/A
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-0.75%
CURRENT VS 3Y AVG
+4.70%
CURRENT VS 5Y AVG
+6.73%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
39.32%
median of 683 covered companies
CURRENT VS SECTOR MEDIAN
-68.08%
vs the sector median at left
Alignment Healthcare, Inc.
Market Cap
$1.73B
Gross Margin
12.55%
TTM Avg
12.64%
3Y Avg
11.99%
5Y Avg
11.76%
Market Cap
$1.74B
Gross Margin
76.47%
TTM Avg
79.35%
3Y Avg
79.86%
5Y Avg
39.87%
Market Cap
$1.72B
Gross Margin
49.52%
TTM Avg
50.81%
3Y Avg
52.12%
5Y Avg
52.25%
Market Cap
$1.79B
Gross Margin
100.00%
TTM Avg
100.00%
3Y Avg
100.00%
5Y Avg
100.00%
Market Cap
$1.65B
Gross Margin
87.11%
TTM Avg
89.24%
3Y Avg
90.16%
5Y Avg
89.75%
Market Cap
$1.82B
Gross Margin
72.90%
TTM Avg
70.08%
3Y Avg
67.68%
5Y Avg
66.96%
Market Cap
$1.64B
Gross Margin
66.15%
TTM Avg
69.48%
3Y Avg
67.43%
5Y Avg
67.56%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Alignment Healthcare, Inc. (ALHC) | $1.73B | 12.55% | 12.64% | 11.99% | 11.76% |
| Intellia Therapeutics, Inc. (NTLA)vs › | $1.74B | 76.47% | 79.35% | 79.86% | 39.87% |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $1.72B | 49.52% | 50.81% | 52.12% | 52.25% |
| Personalis, Inc. (PSNL)vs › | $1.72B | 22.65% | 27.17% | 24.91% | 27.04% |
| Generate Biomedicines, Inc. (GENB)vs › | $1.79B | 100.00% | 100.00% | 100.00% | 100.00% |
| Ocular Therapeutix, Inc. (OCUL)vs › | $1.65B | 87.11% | 89.24% | 90.16% | 89.75% |
| LeMaitre Vascular, Inc. (LMAT)vs › | $1.82B | 72.90% | 70.08% | 67.68% | 66.96% |
| Alphatec Holdings, Inc. (ATEC)vs › | $1.64B | 66.15% | 69.48% | 67.43% | 67.56% |
| Novocure Ltd (NVCR)vs › | $1.83B | 76.13% | 75.94% | 76.33% | 77.05% |
| ANI Pharmaceuticals, Inc. (ANIP)vs › | $1.63B | 51.01% | 55.14% | 57.28% | 56.79% |
Gross Margin
12.6%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 13.55% |
| 2026-03-31 | 11.70% |
| 2025-12-31 | 12.18% |
| 2025-09-30 | 12.65% |
| 2025-06-30 | 13.15% |
| 2025-03-31 | 11.44% |
| 2024-12-31 | 12.31% |
| 2024-09-30 | 11.41% |
| 2024-06-30 | 11.15% |
| 2024-03-31 | 8.81% |
| 2023-12-31 | 10.23% |
| 2023-09-30 | 12.88% |
| 2023-06-30 | 11.19% |
| 2023-03-31 | 9.76% |
| 2022-12-31 | 9.90% |
| 2022-09-30 | 13.18% |
| 2022-06-30 | 16.16% |
| 2022-03-31 | 12.09% |
| 2021-12-31 | 12.98% |
| 2021-09-30 | 13.45% |
| 2021-06-30 | 11.19% |
| 2021-03-31 | 5.99% |
| 2020-12-31 | 11.30% |
| 2020-09-30 | 23.31% |
| 2020-06-30 | 20.39% |
| 2020-03-31 | 13.91% |
